Literature Collection

Magnifying Glass
Collection Insights

13K+

References

11K+

Articles

1700+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 13,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
13146 Results
4841
Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings
Type: Journal Article
Authors: N. J. Pauly, S. Slavova, C. Delcher, P. R. Freeman, J. Talbert
Year: 2018
Topic(s):
Financing & Sustainability See topic collection
,
Opioids & Substance Use See topic collection
4842
Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care
Type: Journal Article
Authors: P. A. Strickland, S. V. Hudson, A. Piasecki, K. Hahn, D. Cohen, A. J. Orzano, M. L. Parchman, B. F. Crabtree
Year: 2010
Publication Place: United States
Abstract: BACKGROUND: The Chronic Care Model (CCM) was developed to improve chronic disease care, but it may also inform delivery of other types of preventive care. Using hierarchical analyses of service delivery to patients, we explored associations of CCM implementation with diabetes care and counseling for diet or weight loss and physical activity in community-based primary care offices. METHODS: Secondary analysis focused on baseline data from 25 practices (with an average of 4 physicians per practice) participating in an intervention trial targeting improved colorectal cancer screening rates. This intervention made no reference to the CCM. CCM implementation was measured through staff and clinical management surveys and was associated with patient care indicators (chart audits and patient questionnaires). RESULTS: Overall, practices had low levels of CCM implementation. However, higher levels of CCM implementation were associated with better diabetes assessment and treatment of patients (P = .009 and .015, respectively), particularly among practices open to "innovation." Physical activity counseling for obese and, particularly, overweight patients was strongly associated with CCM implementation (P = .0017), particularly among practices open to "innovation"; however, this association did not hold for overweight and obese patients with diabetes. CONCLUSIONS: Very modest levels of CCM implementation in unsupported primary care practices are associated with improved care for patients with diabetes and higher rates of behavioral counseling. Incremental incorporation of CCM components is an option, especially for community practices with stretched resources and with cultures of "innovativeness."
Topic(s):
General Literature See topic collection
4843
Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges
Type: Journal Article
Authors: Jennifer B. Saunders, Marian P. Jarlenski, Robert Levy, Katy B. Kozhimannil
Year: 2018
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
4844
Federal Nondiscrimination Laws and Opioid Use Disorders [Video]
Type: Government Report
Year: 2018
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

4845
Federal plan for prescriber education on opioids misses opportunities
Type: Journal Article
Authors: W. C. Becker, D. A. Fiellin
Year: 2012
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
4846
Federal Policy Changes Must Occur To Provide A Lifesaving Stimulant Drug Intervention
Type: Report
Authors: Michael G. McDonell, Katherine Hirchak, Erin McCrady, Westley Clark, Richard Rawson
Year: 2024
Publication Place: Washington, DC
Topic(s):
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

4849
Federally Qualified Health Centers Use of Telehealth to Deliver Integrated Behavioral Health Care During COVID-19
Type: Journal Article
Authors: B. M. Lombardi, de Saxe Zerden, C. Greeno
Year: 2024
Topic(s):
Education & Workforce See topic collection
,
HIT & Telehealth See topic collection
,
Financing & Sustainability See topic collection
4850
Fee-For-Service Will Remain A Feature Of Major Payment Reforms, Requiring More Changes In Medicare Physician Payment
Type: Journal Article
Authors: P. B. Ginsburg
Year: 2012
Topic(s):
Financing & Sustainability See topic collection
4851
Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
Type: Journal Article
Authors: C. L. Barry
Year: 2018
Abstract: Major policy efforts are being aimed at combating the epidemic of opioid addiction and overdose deaths. In response to the epidemic, the medical community and policy makers have attempted to intervene; to date, these varied approaches have done little to reverse the increase in mortality related to opioid overdose. One factor that has complicated efforts to control overdose deaths has been the emergence of a public health crisis related to illicit fentanyl. The rise in fentanyl-related overdose deaths means that new approaches are needed to combat the opioid epidemic, including adoption of harm reduction strategies. Specific strategies that should be considered as part of efforts to combat the opioid crisis include safe drug consumption sites, anonymous drug-checking services, updated naloxone distribution policies, harm reduction-oriented policing, expansion of evidence-based pharmacological treatments in criminal justice and emergency department settings, and stigma-reduction messaging emphasizing the risks of fentanyl.
Topic(s):
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
4852
Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report
Type: Report
Authors: Reagan-Udall Foundation for Food and Drug Administration
Year: 2022
Publication Place: Washington, D.C.
Topic(s):
Grey Literature See topic collection
,
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

4853
Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report
Type: Report
Authors: Reagan-Udall Foundation for Food and Drug Administration
Year: 2022
Publication Place: Washington, D.C.
Topic(s):
Grey Literature See topic collection
,
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

4855
Fentanyl overdose concerns among people who inject drugs: The role of sex, racial minority status, and overdose prevention efforts
Type: Journal Article
Authors: Abenaa Acheampong Jones, Kristin E. Schneider, Christa T. Mahlobo, Jennifer L. Maggs, Lauren Dayton, Karin E. Tobin, Carl A. Latkin
Year: 2023
Topic(s):
Healthcare Disparities See topic collection
4856
Fentanyl Testing to Prevent Overdose - Information for People Who Use Drugs and Healthcare Providers
Type: Report
Authors: California Department of Public Health Office of AIDS
Year: 2023
Publication Place: Sacramento, CA
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

4857
Few Patients Are Treated for Both Obesity and Depression
Type: Journal Article
Authors: E. Pfoh, N. Guo, M. Rothberg
Year: 2025
Abstract:

OBJECTIVES: Understanding the epidemiology of treatment for patients with co-occurring depression and obesity can inform care quality. The objective of the study was to identify how patients with obesity and newly diagnosed depression are treated and whether treatment is associated with body mass index change. METHODS: This cohort study included adults with obesity and newly diagnosed depression who had ≥2 primary care visits between 2015 and 2020 at a large integrated health system. Treatment within 45 days of a depression diagnosis was identified, including antiobesity medication and group or individual weight management visits (eg, bariatric medicine); antidepressant prescriptions; or visits with a psychologist, social worker, or psychiatrist. Patients were grouped into treatment groups: none, depression only, weight management only, or both. Generalized structural equation models were used to identify the association between treatment group and body mass index change at 6 and 12 months, accounting for demographic and health characteristics as fixed variables and clinician identifier as a random variable. RESULTS: Of the 13,729 adults, 43% received depression treatment, 3% received weight management treatment, and 4% received both. Individuals who received weight management treatment only lost more weight at 6 months (β = -1.0 kg/m(2)) and 12 months (β = -1.07 kg/m(2)) than individuals with no treatment. Individuals who had both treatments lost more weight than individuals with depression treatment alone (6 months: β = -1.07 kg/m(2); 12 months: β = -1.21 kg/m(2)) and underwent a similar average change than those who received weight management treatment alone (P > 0.05). CONCLUSIONS: There is an opportunity to increase treatment for obesity among patients with newly diagnosed depression.

Topic(s):
Healthcare Disparities See topic collection
4858
Field Detection of Drugs of Abuse in Oral Fluid Using the Alere DDS(R)2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Type: Journal Article
Authors: A. J. Krotulski, A. L. A. Mohr, M. Friscia, B. K. Logan
Year: 2018
Publication Place: England
Abstract: The collection and analysis of drugs in oral fluid (OF) at the roadside has become more feasible with the introduction of portable testing devices such as the Alere DDS(R)2 Mobile Test System (DDS(R)2). The objective of this study was to compare the on-site results for the DDS(R)2 to laboratory-based confirmatory assays with respect to detection of drugs of abuse in human subjects. As part of a larger Institutional Review Board approved study, two OF samples were collected from each participant at a music festival in Miami, FL, USA. One OF sample was field screened using the DDS(R)2, and a confirmatory OF sample was collected using the Quantisal OF collection device and submitted to the laboratory for testing. In total, 124 subjects participated in this study providing two contemporaneous OF samples. DDS(R)2 field screening yielded positive results for delta-9-tetrahydrocannabinol (THC) (n = 27), cocaine (n = 12), amphetamine (n = 3), methamphetamine (n = 3) and benzodiazepine (n = 1). No opiate-positive OF samples were detected. For cocaine, amphetamine, methamphetamine and benzodiazepines, the DDS(R)2 displayed sensitivity, specificity and accuracy of 100%. For THC, the DDS(R)2 displayed sensitivity of 90%, specificity of 100% and accuracy of 97.5%, when the threshold for confirmation matched that of the manufacturers advertised cut-off. When this confirmatory threshold was lowered to the analytical limit of detection (i.e., 1 ng/mL), apparent device performance for THC was poorer due to additional samples testing positive by confirmatory assay that had tested negative on the DDS(R)2, demonstrating a need for correlation between manufacturer cut-off and analytical reporting limit. These results from drug-using subjects demonstrate the value of field-based OF testing, and illustrate the significance of selecting an appropriate confirmation cut-off concentration with respect to performance evaluation and detection of drug use.
Topic(s):
Opioids & Substance Use See topic collection
4859
Fifteen-minute consultation: Integrated child health: Part 1 - Why integrated care matters
Type: Journal Article
Authors: B. Holden, S. Adnan, M. Watson
Year: 2026
Abstract:

Integrated care for children and young people in England represents a transformative shift towards holistic, person-centred health services tailored to the needs of local communities. In this first part of a series of three, we describe what we mean by integrated care, and why it is needed now, setting the context for the subsequent parts that detail integrated care's core components and practical implementation.Integrated care addresses multidimensional needs-physical health, mental wellbeing, education and social development-while reducing fragmentation and inefficiency. This approach enables early intervention and improves health equity. Key benefits include streamlined access for families, reduced hospital admissions and better outcomes for vulnerable groups, such as children with complex conditions or those facing social and economic challenges.The evolution of UK child health policy, from the 1959 Platt Report to the 2025 National Health Service 10-Year Health Plan for England, underscores the growing emphasis on multidisciplinary, community-based models. By adopting a whole-population approach-segmenting children by health and social needs rather than rigid pathways-integrated care enables every child to be supported and cared for.Ultimately, integrated care is not just an improvement but a necessity, addressing rising demand, workforce pressures and persistent inequities. It fosters proactive, collaborative systems that prioritise children's wellbeing, offering a sustainable future for child health and care services in England.

Topic(s):
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
4860
Fifteen-minute consultation: Integrated child health: Part 2 - Clinical practice
Type: Journal Article
Authors: Y. Moore, N. McLaughlin, M. Watson
Year: 2026
Abstract:

This article explores the core components of effective integrated care for children and young people, moving beyond theory to present practical implementation. It outlines five essential elements: proactive case identification through risk stratification; multidisciplinary case discussion for holistic care planning; direct, joint clinical care in community settings; continuous professional knowledge sharing; and active engagement of families and communities in co-producing services. These components work synergistically to shift care from a reactive to a preventative model, and to shift care from the hospital to the community. Supported by real-world case studies, the analysis demonstrates how this approach provides holistic, equitable and coordinated care that is tailored to the evolving needs of children and their families. As the second paper in a three-part series, this article bridges the rationale for integrated care established in Part 1, with the practical implementation framework provided in Part 3.

Topic(s):
Healthcare Disparities See topic collection